NEW YORK (GenomeWeb) – Pressure BioSciences today reported its first quarter revenues were up 9 percent year over year despite not recording any grant revenues in the recently completed quarter.

For the three months ended March 31, the South Easton, Mass.-based firm posted $404,147 in revenues, up from $370,737 a year ago. While it had no grant revenues in Q1 2014, compared to $149,168 a year ago, revenues generated from the sales of its products and services and other revenues grew 82 percent to $404,147 from $221,569.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.